merged_engineered-virus-steals-proteins-from-hiv.txt
<question_number>1</question_number>
<answer>N/A</answer>
<other>The article doesn't directly compare TIPs to lenacapavir in terms of protection, only mentions that both might be difficult to maintain in poor countries.</other>

<question_number>2</question_number>
<answer>It might make it harder for people to transmit H.I.V. to others</answer>

<question_number>3</question_number>
<answer>Doctors cannot receive consent from others who might be infected with TIPs beyond the initial patient</answer>

<question_number>4</question_number>
<answer>N/A</answer>
<other>The article doesn't directly compare the mechanisms of action between TIPs and protease inhibitors</other>

<question_number>5</question_number>
<answer>Inability to remove TIPs if unexpected side effects occur</answer>

<question_number>6</question_number>
<answer>TIPs do a better job of entering the shells and release three times more TIPs than H.I.V. viruses</answer>

<question_number>7</question_number>
<answer>Unexpected side effects cannot be removed once TIPs are inserted into DNA</answer>

<question_number>8</question_number>
<answer>N/A</answer>
<other>While Dr. Leeks mentions it's a universal approach, he doesn't specify why</other>

<question_number>9</question_number>
<answer>Cannot obtain consent from people who might be infected with TIPs beyond the initial patient</answer>

<question_number>10</question_number>
<answer>TIPs act as an impostor virus that interferes with H.I.V.'s life cycle, while protease inhibitors prevent a protein from activating H.I.V.</answer>